1. Search Result
Search Result
Results for "

PC-1

" in MedChemExpress (MCE) Product Catalog:

27

Inhibitors & Agonists

6

Biochemical Assay Reagents

3

Peptides

2

Natural
Products

6

Recombinant Proteins

2

Isotope-Labeled Compounds

11

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P1028
    Hexa-D-arginine
    3 Publications Verification

    Furin Inhibitor II

    Bacterial Infection
    Hexa-D-arginine (Furin Inhibitor II) is a stable furin inhibitor with Ki values 106 nM, 580 nM and 13.2 μM for furin, PACE4 and prohormone convertase-1 (PC1), respectively. Hexa-D-arginine blocks Pseudomonas exotoxin A and anthrax toxins toxicity in vitro and in vivo [1] .
    Hexa-D-arginine
  • HY-P5272

    Bacterial Inflammation/Immunology
    Histatin-3 TFA, a 32 amino acid peptide, possesses powerful antimicrobial properties. Histatin-3 TFA behaves as a substrate for proprotein convertase 1 (PC1), being cleaved by this endoprotease primarily at a site carboxy terminal to the single Arg25 residue (HRGYR decrease SN). Histatin-3 TFA is a moderately potent, reversible and competitive inhibitor of the furin-mediated cleavage of the pentapeptide pGlu-Arg-Thr-Lys-Arg-MCA fluorogenic substrate, with an estimated inhibition constant Ki of 1.98 μM [1].
    Histatin-3 TFA
  • HY-W440983

    PC(18:0/22:6); DHA-PC; 1-Stearoyl-2-docosahexaenoyl-sn-glyerco-3-phosphocholine

    PPAR Cardiovascular Disease Cancer
    SDPC (DHA-PC) is a new generation of omega-3 lipids, which contains an ester bond linking DHA at the sn-2 position of phospholipid. 1-Stearoyl-2-docosahexaenoyl-sn-glyerco-3-phosphocholine exerts anti-angiogenesis effect through activating PPARγ. 1-Stearoyl-2-docosahexaenoyl-sn-glyerco-3-phosphocholine significantly declines the proliferation, migration, tube formation of human umbilical vein endothelial cells. 1-Stearoyl-2-docosahexaenoyl-sn-glyerco-3-phosphocholine has the potential for anti-tumor angiogenesis research [1].
    SDPC
  • HY-143857S

    Isotope-Labeled Compounds Others
    22:0 Lyso PC- 13C6 is a 13C-labeled and deuterium labeled 22:0 Lyso PC[1].
    22:0 Lyso PC-13C6
  • HY-159972

    G Protein-coupled Receptor Kinase (GRK) Neurological Disease
    PKR1 antagonist 1 (PC1) is a potent PKR1 antagonist. PKR1 antagonist 1 reduces hyperalgesia and allodynia in SNI mice [1].
    PKR1 antagonist 1
  • HY-P1028A

    Furin Inhibitor II TFA

    Bacterial Infection
    Hexa-D-arginine TFA (Furin Inhibitor II TFA) is a stable furin inhibitor with Ki values 106 nM, 580 nM and 13.2 μM for furin, PACE4 and prohormone convertase-1 (PC1), respectively. Hexa-D-arginine TFA blocks Pseudomonas exotoxin A and anthrax toxins toxicity in vitro and in vivo [1] .
    Hexa-D-arginine TFA
  • HY-RS05191

    Small Interfering RNA (siRNA) Others

    G6PC1 Human Pre-designed siRNA Set A contains three designed siRNAs for G6PC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    G6PC1 Human Pre-designed siRNA Set A
    G6PC1 Human Pre-designed siRNA Set A
  • HY-142988

    1S-2M-PC

    Liposome Others
    1-Stearoyl-2-myristoyl-sn-glycero-3-PC (1S-2M-PC) belongs to the class of asymmetric phospholipids. 1-Stearoyl-2-myristoyl-sn-glycero-3-PC is abundant in biological membranes [1].
    1-Stearoyl-2-myristoyl-sn-glycero-3-PC
  • HY-165157

    16:0p/20:4-PC; PC(P-16:0/20:4); C16(plasm)-20:4-PC

    Biochemical Assay Reagents Others
    1-1(Z)-Hexadecenyl-2-arachidonoyl-sn-glycero-3-PC 是一种生化试剂。
    1-1(Z)-Hexadecenyl-2-arachidonoyl-sn-glycero-3-PC
  • HY-169804

    Phosphodiesterase (PDE) Cancer
    ENPP3 Inhibitor 1 is a selective inhibitor of ENPP3, with IC50s of 0.15 µM (ENPP3) and 41.4 µM (ENPP1) respectively. ENPP3 Inhibitor 1 shows anti-tumor activities against breast cancer and cervical cancer [1].
    ENPP3 Inhibitor 1
  • HY-134154

    PAzePC; Azelaoyl PC; 1-Palmitoyl-2-Azelaoyl PC

    Endogenous Metabolite Metabolic Disease
    Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species which are cytotoxic and pro-atherogenic. Many of these substances were isolated and purified from oxLDL and identified as phosphatidylcholine species containing a fragmented, oxidized short-chain fatty acid remnant at the sn-2 position. PAz-PC (Azelaoyl PC) is one of the predominant oxLDL species and may be one of the important structural determinants of oxLDL.
    PAz-PC
  • HY-167816

    21:0 PC

    Bacterial
    1,2-Diheneicosanoyl-sn-glycero-3-phosphocholine (21:0 PC) is a surfactant with antibacterial activity. 1,2-Diheneicosanoyl-sn-glycero-3-phosphocholine can act in mucus to help prevent the spread of pathogens. 1,2-Diheneicosanoyl-sn-glycero-3-phosphocholine plays a protective role in biofilms, maintaining the health of organisms.
    1,2-Diheneicosanoyl-sn-glycero-3-phosphocholine
  • HY-W340037

    04:0 PC

    Biochemical Assay Reagents
    1, 2-dibutyryl-SN-glycero-3-phosphocholine (04:0 PC) is a biochemical reagent [1].
    1,2-Dibutyryl-sn-glycero-3-phosphocholine
  • HY-157689

    20:1(Cis)PC

    Biochemical Assay Reagents
    1,2-Dieicosenoyl-sn-glycero-3-phosphocholine (20:1(Cis)PC) is a phospholipid that has the activity of promoting the binding of proteins to liposomes. 1,2-Dieicosenoyl-sn-glycero-3-phosphocholine can serve as a component of biological membranes and enhance the fluidity of cell membranes. 1,2-Dieicosenoyl-sn-glycero-3-phosphocholine also plays an important role in compound delivery systems, improving the biocompatibility and targeting of compounds.
    1,2-Dieicosenoyl-sn-glycero-3-phosphocholine
  • HY-166989

    11:0 Lyso PC

    Biochemical Assay Reagents Others
    1-Undecanoyl-sn-glycero-3-phosphocholine is a biochemical assay reagent.
    1-undecanoyl-2-hydroxy-sn-glycero-3-phosphocholine
  • HY-165997

    PC-(P16:0/16:0)

    Biochemical Assay Reagents Metabolic Disease
    1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC is an ester product.
    1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC
  • HY-131652

    16:0 Diether PC

    Liposome Metabolic Disease
    1,2-Di-O-hexadecyl-sn-glycero-3-phosphocholine (16:0 Diether PC) is a synthetic ether-linked phospholipid containing hexadecyl groups at the sn-1 and sn-2 positions. It is commonly used in the generation of liposomes and artificial membranes to study membrane dynamics.
    1,2-Di-O-hexadecyl-sn-glycero-3-phosphocholine
  • HY-126359

    SLPC; 18:0-18:2 PC

    Endogenous Metabolite Metabolic Disease
    1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine can be chosen as a model used to investigate the volatile compounds from oxidised phosphatidylcholine molecular species. This method is applied to a real food sample, i.e. soy lecithin [1].
    1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine
  • HY-113123

    14:0 Lyso PC; 1-myristoyl-sn-glycero-3-phosphatidylcholine

    Endogenous Metabolite Neurological Disease Metabolic Disease
    LysoPC(14:0/0:0) is a lysophospholipid (LyP). It is a monoglycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. LysoPC(14:0/0:0) has potent antispasmodic effect [1].
    LysoPC(14:0/0:0)
  • HY-W040193
    DSPC
    3 Publications Verification

    1,2-Distearoyl-sn-glycero-3-PC; 1,2-Distearoyl-sn-glycero-3-phosphorylcholine

    Liposome Others
    DSPC (1,2-Distearoyl-sn-glycero-3-phosphorylcholine) is a cylindrical-shaped lipid. DSPC is used to synthesize liposomes, and is the lipid component in the lipid nanoparticle (LNP) system [1] .
    DSPC
  • HY-122056

    L-α-Diheptanoyllecithin; 12-Diheptanoyl-sn-glycero-3-PC

    Biochemical Assay Reagents Metabolic Disease
    1,2-Diheptanoyl-SN-glycero-3-phosphocholine (L-α-Diheptanoyllecithin; 12-Diheptanoyl-sn-glycero-3-PC) is an ester product.
    1,2-Diheptanoyl-SN-glycero-3-phosphocholine
  • HY-W322575

    DHPC

    Liposome Others
    1,2-Diheptadecanoyl-sn-glycero-3-phosphorylcholine (DHPC) is a biologically active phospholipid compound and a derivative of phosphatidylcholine (PC) . It can be used in the generation of micelles, liposomes, and other types of artificial membranes.
    1,2-Diheptadecanoyl-sn-glycero-3-phosphorylcholine
  • HY-157698

    C18(plasm)-20:4-PC; 18:0p/20:4-PC; PC(P-18:0/20:4)

    Endogenous Metabolite Metabolic Disease
    1-1(Z)-Octadecenyl-2-arachidonoyl-sn-glycero-3-PC is a plasmalogen that contains 1(Z)-octadecenoic acid and arachidonic acid (HY-109590) at the sn-1 and sn-2 positions, respectively. It scavenges singlet oxygen in a cell-free assay.
    1-1(Z)-Octadecenyl-2-arachidonoyl-sn-glycero-3-PC
  • HY-107416

    U-57908

    DAGL Acyltransferase mAChR COX Phospholipase Neurological Disease Metabolic Disease
    RHC 80267 (U-57908) is a potent and selective inhibitor of diacylglycerol lipase (DAGL) (with IC50 of 4 μM in canine platelets). RHC-80267 inhibits cholinesterase activity with an IC50 of 4 μM, thereby enhancing the relaxation evoked by acetylcholine. RHC 80267 also inhibits COX and the hydrolysis of phosphatidylcholine (PC) .
    RHC 80267
  • HY-W923483

    1-O-Hexadecyl-2-oleoyl-sn-glycero-3-phosphocholine

    Others Cardiovascular Disease
    C16-18:1 PC (1-O-Hexadecyl-2-oleoyl-sn-glycero-3-phosphocholine), also known as 1-O-hexadecyl-2-oleoyl-sn-glycero-3-phosphocholine (HOPC), is a member of the platelet-activating factor (PAF) family of glycerophospholipids and serves as a pro-inflammatory lipid mediator with diverse biological and pharmacological effects; it features a mono-ether structure with an oleoyl chain (18:1) ester-linked at the sn-2 position and a hexadecyl chain (16:0) ether-linked at the sn-1 position.
    C16-18:1 PC
  • HY-130462S2

    POPC-13C16; 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine-13C16

    Isotope-Labeled Compounds Liposome Others
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC- 13C16 (POPC- 13C16) is 13C labeled 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC. 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC (POPC), a phospholipid, is a major component of biological membranes. 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC is used for the preparation of liposomes and studying the properties of lipid bilayers [1] [1] .
    1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-13C16
  • HY-133233

    1-Palmitylthio-2-palmitoylamido-1,2-dideoxy-sn-glycero-3-phosphorylcholine

    Endogenous Metabolite Phospholipase Metabolic Disease
    Thioetheramide-PC (1-Palmitylthio-2-palmitoylamido-1,2-dideoxy-sn-glycero-3-phosphorylcholine) is a structurally modified phospholipid that acts as a competitive, reversible inhibitor of secretory phospholipase A2 (sPLA2). Thioetheramide-PC has an IC50 value of 2 μM at a substrate concentration of 0.5 mM. In addition to binding to the catalytic site of sPLA2, Thioetheramide-PC also binds to the activation site of the enzyme. Thioetheramide-PC binds more tightly to the activation site than to the catalytic site. As a result of this dual interaction, at low concentrations, Thioetheramide-PC may activate phospholipase activity rather than inhibit it.
    Thioetheramide-PC

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: